Stocks & Investing
Stocks and Investing
Stocks and Investing 
Tue, June 30, 2009
Mon, June 29, 2009
YAVY, UEC, CTFO, PLX, END, CPD. Abnormal Price Friction In Morning Trading Session Today
June 29, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for June 29, 2009. Since late October market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This fair market making requirement is designed to prevent market makers from manipulating stock prices. Here is a list of the companies with Abnormal Price Friction (unfair market) in their stock prices in today�s trading session. This means that there was more buying than selling in the stocks and their stock prices dropped. Yadkin Valley Financial (NASDAQ: YAVY), Uranium Energy Corp (AMEX: UEC), China Transinfo Technology (NASDAQ: CTFO), Protalix Bio Therapeutics (AMEX: PLX), Endeavour International (AMEX: END) and Caraco Pharmaceutical Laboratories (AMEX: CPD). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction
YAVY -$0.75 -9.84% 20,455 51.98% 18,499 47.01% 1,956 abnormal
UEC -$0.58 -17.21% 710,176 48.63% 614,864 42.10% 95,312 abnormal
CTFO -$0.48 -9.64% 12,606 57.78% 9,211 42.22% 3,395 abnormal
PLX -$0.45 -8.59% 97,791 41.92% 44,915 19.25% 52,876 abnormal
END -$0.37 -19.84% 61,525 42.36% 57,990 39.92% 3,535 abnormal
CPD -$0.29 -8.55% 56,434 66.99% 18,024 21.40% 38,410 abnormal
Click here to view chart: 
Analysis of the Friction Factor chart above shows that each of the stocks mentioned above had more buying than selling on Monday, June 29th, 2009 and their stock prices dropped. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows YAVY with 1,956 greater shares of buying than selling (NetVol) and the stock price is down -$0.75. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more buying than selling should cause prices to rise.
Yadkin Valley Financial Corporation (NASDAQ: YAVY) operates as the holding company for Yadkin Valley Bank and Trust Company that provides consumer and commercial banking services to individuals, and small and medium-sized businesses in northwestern North Carolina. Its deposit products include checking and savings accounts, money market accounts, interest-bearing deposits accounts, noninterest-bearing demand deposits, negotiable order of withdrawal accounts, certificates of deposit, and individual retirement accounts. The company�s portfolio of loans includes consumer loans, commercial loans, home equity loans, home mortgages, commercial real estate construction and mortgage loans, residential real estate construction and development loans, installment loans, and commercial mortgage loans. It also provides mortgage brokerage, insurance, investment, and automated teller machine services, as well as serves as a trustee. As of May 11, 2009, the company operated 32 banking offices. Yadkin Valley Financial Corporation was founded in 1968 and is headquartered in Elkin, North Carolina.
Uranium Energy Corp. (AMEX: UEC), a natural resource exploration company, engages in the acquisition and exploration of uranium properties in the United States. As of July 31, 2008, the company held interests in approximately 63,562.87 gross acres of leased or staked mineral properties, which included claim blocks located in Arizona, Colorado, New Mexico, Texas, Utah, and Wyoming. Uranium Energy Corp., formerly Carlin Gold, Inc., was founded in 2003 and is based in Austin, Texas.
China TransInfo Technology Corp. (NASDAQ: CTFO) provides public transportation information systems technology and solutions in China. Its products include transportation planning information system, a software system utilized by traffic management engineers to plan roads and water transportation, safety monitoring, and conduct strategic planning; pavement maintenance system, a business application system for pavement data collection and operations management; and electronic toll collection, a technology that allows for electronic payment of tolls. The company also offers traffic information service system, a software system that provides real time road conditions and related information; taxi LED GPS monitoring and coordinating system for GPS, transmitting photos, alarms and information distribution, and vehicle dispatch by calls; GIS-T (transportation) middleware, which helps the user in establishing own application systems without significant customizations; and dynamic traffic information service platform to collect, process, distribute, and operate traffic information. In addition, it provides palmcity navigation engine, which integrates mapping and navigation into Windows CE and Internet applications; and comprehensive location based service platform, a transportation information service platform based on GIS, GPS, ITS, and communication technologies. Further, it offers traffic flow surveying solutions, intelligent parking systems, red light violation snapshot systems, intelligent highway vehicle monitoring systems, intelligent traffic management platforms, and intelligent public transport systems; and software platforms that utilize 2-D and 3-D GIS. The company markets and sells its products and services to highway information systems, urban intelligent transportation systems, digital city, and land and resources segments within the government and regulated sectors. China TransInfo Technology Corp. is based in Beijing, China.
Protalix BioTherapeutics, Inc. (AMEX: PLX), a biopharmaceutical company, engages in the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in the United States. Its lead product candidate includes prGCD, a proprietary plant cell expressed recombinant Glucocerebrosidase enzyme for the treatment of Gaucher disease, which is in Phase III clinical trial. The company also develops PRX-102, a proprietary alpha Galactosidase enzyme for the treatment of Fabry disease, a genetic lysosomal storage disorder in humans, the symptoms of which involve the accumulation of lipids in the cells of the kidneys, heart, and other organs; a proprietary plant cell-based acetylcholinestrase and its molecular variants for use in various therapeutic and prophylactic indications, including a Biodefense program; and an organophosphate-based pesticide treatment program. Protalix BioTherapeutics, Inc. has strategic collaboration with Teva Pharmaceutical Industries, Ltd. for the development and manufacturing of two proteins using the company�s ProCellEx protein expression system; and Yeda Research and Development Company Limited to design Glucocerebrosidase for the treatment of Gaucher disease, as well as has a licensing agreement with Icon Genetics AG to license Icon�s amplification technology for utilization in the expression of its products. The company was founded in 1993 and is based in Carmiel, Israel.
Endeavour International Corporation (AMEX: END), an independent energy company, focuses on the acquisition, exploration, and development of energy reserves in the North Sea and United States. The company has three major development projects in the United Kingdom sector of the North Sea and an exploration campaign onshore South Texas. As of December 31, 2008, it had proved reserves of 32,797 million cubic feet of natural gas; and 3,555 thousands of barrels of crude oil, condensate, and natural gas liquids. The company was founded in 2000 and is based in Houston, Texas.
Caraco Pharmaceutical Laboratories, Ltd. (AMEX: CPD) engages in the development, manufacture, marketing, and distribution of generic, prescription, and over-the-counter pharmaceuticals for wholesalers, distributors, warehousing and non-warehousing chain drugstores, and managed care providers in the United States and Puerto Rico. It offers therapeutic drugs, such as analgesics, anorectics, antiallergics, antianxiety, antibiotics, anticonvulsants, antidepressants, antidiabetics, antiematics, anti-gouts, antihypertensive/beta blockers, antipsychotics, antithryoid agents, antitussive, anti ulcerants, bisphosphonate derivatives, calcium channel blockers, cardiac, decongestants, and narcotic analgesics. The company�s therapeutic drugs also include nonsteroidal antiinflammatory agents, opiate agonist/analgesics, oncology adjuncts, Parkinson�s disease, platelet aggregation inhibitors, sedatives and hypnotics, skeletal muscle relaxants, and vascular and migraine headache suppressants. It offers its products for central nervous system, cardiology, pain management, and diabetes. The company was founded in 1984 and is based in Detroit, Michigan. Caraco Pharmaceutical Laboratories, Ltd. is a subsidiary of Sun Pharmaceutical Industries Limited.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,600,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State. Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net